Stock Events

Stock Events

Quest Pharmatech 

$0.030000
3
+$0.01+50%Monday 14:56

Statistics

Day High
0.03
Day Low
0.03
52W High
0.031
52W Low
0.0133
Volume
5,000
Avg. Volume
6,140
Mkt Cap
922,230
P/E Ratio
1
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Jul 2005
$0.05
Apr 2005
$0.05
Jan 2005
$0.05
Oct 2004
$0.05
Jul 2004
$0.05
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

Jul 12Expected
Q2 2022
Q2 2024
-0
0.33
0.66
1
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
0Revenue
3.66MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Merck
MRK
Mkt Cap356.01B
Merck & Co., Inc. is a global healthcare company that develops medications and vaccines, competing directly with Quest Pharmatech in the oncology and immunotherapy sectors.
Pfizer
PFE
Mkt Cap158.45B
Pfizer Inc. is involved in the discovery, development, and manufacture of healthcare products including innovative medicines and vaccines, directly competing in the biopharmaceutical field.
Bristol-Myers Squibb
BMY
Mkt Cap124.91B
Bristol-Myers Squibb Company is a global biopharmaceutical company with a strong portfolio in cancer treatment, immunology, and cardiovascular diseases, making it a direct competitor.
Novartis
NVS
Mkt Cap268B
Novartis AG focuses on patented medicines, generics, and biosimilars, with significant investments in research and development in areas overlapping with Quest Pharmatech's interests.
Gilead Sciences
GILD
Mkt Cap179.47B
Gilead Sciences, Inc. is a biopharmaceutical company that researches, develops, and commercializes drugs in areas such as oncology, competing in similar therapeutic areas as Quest Pharmatech.
AMGEN
AMGN
Mkt Cap217.9B
Amgen Inc. is a biotechnology company focusing on cardiovascular disease, oncology/hematology, and other areas, directly competing with Quest Pharmatech in biopharmaceuticals.
Abbvie
ABBV
Mkt Cap464.43B
AbbVie Inc. is a research-based biopharmaceutical company with a strong emphasis on immunology, oncology, and virology, areas that overlap with Quest Pharmatech's focus.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is a pioneer in healthcare, focusing on pharmaceuticals and diagnostics in oncology, immunology, and infectious diseases, making it a competitor.
Astrazeneca
AZN
Mkt Cap243.34B
AstraZeneca PLC is a global, science-led biopharmaceutical business that focuses on the discovery, development, and commercialization of prescription medicines, including in areas competing with Quest Pharmatech.
Johnson & Johnson
JNJ
Mkt Cap617.01B
Johnson & Johnson is a diverse healthcare company that develops and sells pharmaceuticals, medical devices, and consumer health products, competing across several of Quest Pharmatech's key areas.

About

Quest PharmaTech Inc. (QPTFF), an Edmonton, Canada-based pharmaceutical firm, specializes in creating antibody-driven immunotherapeutic remedies primarily for various cancers. A cornerstone of its product pipeline is Mab AR 9.6, an advanced therapeutic candidate specifically designed to target truncated O-glycans on MUC16 for precise cancer treatment applications. The company's offerings further encompass Oregovomab, an anti-CA-125 antibody that has successfully completed Phase II clinical trials for the management of ovarian cancer. Beyond these specific agents, Quest PharmaTech is actively involved in the development, manufacturing, and commercialization of new immunotherapy products aimed at combating pancreatic cancer. The organization also diversifies its portfolio by utilizing proprietary transdermal delivery technologies to formulate products for dermatological conditions and wound healing. Additionally, it develops specialized skin-penetrating active molecules for use in both cosmetic and pharmaceutical goods. Rounding out its innovative efforts, Quest PharmaTech designs intricate combinatorial immunotherapies for cancer, employing monoclonal antibodies belonging to both immunoglobulin G and E classes.
Show More
CEO
Ragupathy Madiyalakan
Employees
3
Country
Canada
ISIN
CA74836M1068

Listings

OTC Link
US
QPTFF
V
CA
QPT.V

0 Comments

Share your thoughts

FAQs

What is Quest Pharmatech stock price today?▼
The current price of QPTFF is $0.03 USD — it has increased by +50% in the past 24 hours. Watch Quest Pharmatech stock price performance more closely on the chart.
What is Quest Pharmatech stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Quest Pharmatech stocks are traded under the ticker QPTFF.
Is Quest Pharmatech stock price growing?▼
QPTFF stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Quest Pharmatech has showed a +125.56% increase.
What is Quest Pharmatech market cap?▼
Today Quest Pharmatech has the market capitalization of 922,230
What were Quest Pharmatech earnings last quarter?▼
QPTFF earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Quest Pharmatech revenue for the last year?▼
Quest Pharmatech revenue for the last year amounts to 0 USD.
What is Quest Pharmatech net income for the last year?▼
QPTFF net income for the last year is 3.66M USD.
How many employees does Quest Pharmatech have?▼
As of October 21, 2026, the company has 3 employees.
In which sector is Quest Pharmatech located?▼
Quest Pharmatech operates in the Health & Wellness sector.
When did Quest Pharmatech complete a stock split?▼
Quest Pharmatech has not had any recent stock splits.
Where is Quest Pharmatech headquartered?▼
Quest Pharmatech is headquartered in Edmonton, Canada.